Obituary: Rudolf Kunze
22.05.2023
On monday, May 22nd 2023 our great friend mentor and provider of ideas Dr. Rudolf Kunze passed away, peacefully. He leaves a great void. We miss him.
22.05.2023
On monday, May 22nd 2023 our great friend mentor and provider of ideas Dr. Rudolf Kunze passed away, peacefully. He leaves a great void. We miss him.
28.11.2022
The FDA has granted PentraSorb CRP designation as a Breakthrough Device. A remarkable achievement.
19.05.2022
Pentracast is the name of our new, informative podcast in which various employees, users and many others answer questions from our medical device consultant Henrike Weß.
This is the second part of the conversation between Henrike and Oliver
10.08.2021
Pentracor recently joined the BVMed business association, which represents the interests of the German medtech industry and, in particular, medtech SMEs. BVMed represents around 220 industrial and commercial companies in the medical technology sector. Among others, the world's 20 largest medical device manufacturers in the consumer goods sector are organized in BVMed.
03.12.2020
To meet the strict hygiene requirements for emergency overnight stays, the Berliner Stadtmission has an increasing need for Corona rapid tests for guests and staff.
14.10.2020
Der 100. Patient wurde dieser Tage mit der CRP-Apherese behandelt. Diese Behandlung lief im Rahmen der CABY1-Studie (CRP-Apherese nach koronarer Bypass-Operation) und wurde wie gewohnt sicher durchgeführt. Wir freuen uns, dass nun schon 100 Patienten von der Therapie profitieren konnten und hoffen, noch zahlreichen weiteren Menschen helfen zu können.
25.08.2020
On August 25, 2010, Dr. Ahmed Sheriff together with Birgit Vogt, Dr. Rudolf Kunze, Stephan Hiller and Dr. Bernd Wegener founded Pentracor GmbH to implement the idea of CRP apheresis for acute inflammation-driven diseases such as myocardial infarction.